Salud
Con una tecnología nueva y disruptiva que desafía constantemente el statu quo, el sector de la salud avanza a pasos agigantados. Pero en un sector basado en la normativa, las asociaciones estratégicas suelen ser la clave para desarrollar con éxito los negocios. Nuestros asesores, respaldados por equipos subsectoriales en todo el mundo, utilizan su profunda experiencia en fusiones y adquisiciones, capital de crecimiento y ECM, asesoramiento en materia de deuda y servicios de financiación empresarial para encontrar su ventaja competitiva, navegar por las culturas locales y ayudarle a crear la estrategia más adecuada.
Contactar un Advisor
Olyos Group has acquired a controlling stake in NewScience
Olyos Group has acquired a controlling stake in NewScience from its founders through a transaction structured in two stages, with the strategic objective of ultimately acquiring 100% of the company. The transaction forms part of NewScience’s international growth strategy and a gradual cash-out process for the founder, who intends to complete a full exit. Olyos intends to retain the management team through a put and call option mechanism and an earn-out linked to NewScience’s 2025 EBITDA.
Ver másBanook, backed by Motion Equity, has acquired Fluidda
Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.
Ver másmove UP has been acquired by Acture B.V.
move UP Gesellschaft für Gesundheitsmanagement mbH, an innovative provider of holistic corporate health management solutions, has been acquired by Acture B.V., a leader in welfare management. This acquisition represents a major step in Acture’s plans to expand into the German corporate health management sector.
Ver más
Jan De Backer
CEO, Fluidda NV
Seguir leyendo
New chapters, global ambitions: mid-market M&A in Q4
QUARTERLY M&A ACTIVITY: In Q4 2025, Oaklins' clients completed 93 transactions across sectors and regions, highlighting how business leaders are using M&A to drive growth, succession and strategic change.
Ver más